2018
DOI: 10.1016/j.parkreldis.2017.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Promising non-pharmacological therapies in PD: Targeting late stage disease and the role of computer based cognitive training

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(19 citation statements)
references
References 24 publications
0
19
0
Order By: Relevance
“… a Noncomprehensive considerations for gamified cognitive training design (in the field of Parkinson disease); not presented in order of priority and obtained from the wider literature [7,13,15,16,19,20,30,36-39]. …”
Section: Discussionmentioning
confidence: 99%
“… a Noncomprehensive considerations for gamified cognitive training design (in the field of Parkinson disease); not presented in order of priority and obtained from the wider literature [7,13,15,16,19,20,30,36-39]. …”
Section: Discussionmentioning
confidence: 99%
“…Physiotherapy for individuals with severe neurological disorders requires careful assessment of motor, cognitive and emotional impairments. In some cases, patients are not able to perform their exercises without the therapist's assistance (48,49).…”
Section: Telehealth-a Solution For Addressing the Increased Frailty Imentioning
confidence: 99%
“…LSPD patients’ assessment and treatment reflect a long list of clinical unmet needs [ 41 ]. Most of the instruments available to assess LSPD patients seem to be partially adequate or mostly inadequate, probably because clinometric properties of such scales have not been specifically tested among LSPD patients, who are difficultly testable due to dementia, behavioral disorders and severe dysarthria.…”
Section: Bottlenecksmentioning
confidence: 99%
“…Equally, non-pharmacological interventions are not adapted to these frail and demented patients. This is one of the reason why, when we extrapolate data of HY 4–5 patients from small trials on multidisciplinary or home-based exercise and strategy training, no improvement is found, for instance, on ADLs or falls [ 41, 42 ]. Additionally, the neuropathology of levodopa unresponsive motor or NMS, remains largely undefined, besides the fact there are no new marketed drugs that properly target those symptoms [ 43 ].…”
Section: Bottlenecksmentioning
confidence: 99%